📍Recalling firmPD-Rx Pharmaceuticals, Inc.727 N Ann Arbor Ave · Oklahoma City, OK 73127-5822
✎ GovInfoNow plain-language explainer
PD-Rx Pharmaceuticals, Inc. is recalling 9 bottles of Clonidine Hydrochloride Tablets, USP, 0.1 mg, packaged in 100-count bottles. The recall was initiated because the product was manufactured with current Good Manufacturing Practice (cGMP) deviations. These deviations may affect the quality and safety of the medication. Read more at govinfonow.com/recall/44099-pd-rx-pharmaceuticals-inc-recalls-clonidine-hydrochloride-tablets-usp-0.
“PD-Rx Recalls Clonidine Tablets Due to cGMP Deviations.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44099-pd-rx-pharmaceuticals-inc-recalls-clonidine-hydrochloride-tablets-usp-0. Based on FDA recall #D-0559-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0559-2016%22&limit=1).
PD-Rx Pharmaceuticals, Inc. recalled Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100-count bottles on July 10, 2015, due to current Good Manufacturing Practice deviations, the Food and Drug Administration said. The recall affects nine bottles distributed in Alabama.
Manufacturer: Mutual Pharm. Co. Inc., Philadelphia, PA 19124
Packager: PD-RX Pharmaceuticals, Inc., Oklahoma City, OK 73127
Distribution: Alabama
Quantity: 9 bottles
The hazard
The recall is due to current Good Manufacturing Practice deviations. The FDA classified the recall as Class II.
Context
GovInfoNow's records show PD-Rx Pharmaceuticals, Inc. has had 16 other recalls on record since April 29, 2015. Other recent recalls of similar products include a Duloxetine 30mg recall (Dec. 4, 2024), a Simvastatin 40mg recall (April 6, 2023), and a Losartan Tablets recall (June 6, 2022). Other recent recalls of similar products include a Fentanyl Citrate Injectable Solution recall by Wells Pharma (April 1, 2026), a Globe Clotrimazole Cream recall by Blossom Pharmaceuticals (Oct. 31, 2025), and a Clindamycin Injection recall by Baxter (Aug. 6, 2026).
How to tell if you have this one
Check your medication bottle for the following details: Brand/Packager PD-Rx Pharmaceuticals, Inc.; NDC 43063-509-01; Lot# B14D26; Expiration date 02/16. The product is Clonidine Hydrochloride Tablets, USP, 0.1 mg in 100-count bottles.
Brand
PD-Rx Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Medication
Verify if your bottle matches NDC 43063-509-01, Lot# B14D26, and expires on 02/16.
Contact Your Pharmacist
Speak with your pharmacist or healthcare provider to determine if you have the recalled lot and what steps to take next.
Where it went and when
Where it was distributed
Distributed in Alabama.
Listed by the agency
Not listed
FDA distribution: “Alabama” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Alabama.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0559-2016 (July 10, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0559-2016 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.